Literature DB >> 3962966

The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival.

C E Henke, G Henke, L R Elveback, C M Beard, D J Ballard, L T Kurland.   

Abstract

Using the unique data resources of the Rochester Epidemiology Project, a community-based study of clinically diagnosed sarcoidosis was conducted. In this population-based study, the 75 Rochester, Minnesota, residents with sarcoidosis initially diagnosed between 1946 and 1975 (incidence cohort) were followed through their comprehensive medical records in the community to January 1, 1982. The age- and sex-adjusted incidence of sarcoidosis was 6.1 per 100,000 person-years. The age-adjusted incidence of sarcoidosis was similar in males (5.9) and females (6.3), with a peak incidence in males 30 to 39 years old (18.7) and in females 40 to 49 years old (15.6). A secular increase in sarcoidosis incidence was noted in the period 1946-1975 for females, with a marked increase in the number and percentage of biopsy-documented cases. Seasonal variation in sarcoidosis incidence was minimal, with a seasonal peak of 31% of the Rochester cases being diagnosed during the spring (March-May). Survival, compared with that of the North Central United States, was unimpaired in this sarcoidosis incidence cohort.

Entities:  

Mesh:

Year:  1986        PMID: 3962966     DOI: 10.1093/oxfordjournals.aje.a114313

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  39 in total

1.  Effect of smoking and gender on pulmonary function and clinical features in sarcoidosis.

Authors:  Willane Krell; Julie M Bourbonnais; Rajat Kapoor; Lobelia Samavati
Journal:  Lung       Date:  2012-07-08       Impact factor: 2.584

Review 2.  Disease Burden and Variability in Sarcoidosis.

Authors:  Alicia K Gerke; Marc A Judson; Yvette C Cozier; Daniel A Culver; Laura L Koth
Journal:  Ann Am Thorac Soc       Date:  2017-12

3.  Clinical characteristics of biopsy-proven renal sarcoidosis in Japan.

Authors:  Yoshinori Kamata; Hiroshi Sato; Kensuke Joh; Yoshinori Tsuchiya; Shinobu Kunugi; Akira Shimizu; Tsuneo Konta; Robert P Baughman; Arata Azuma
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

4.  Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16.

Authors:  G Tromp; H Kuivaniemi; S Raphael; L Ala-Kokko; A Christiano; E Considine; R Dhulipala; J Hyland; A Jokinen; S Kivirikko; R Korn; S Madhatheri; S McCarron; L Pulkkinen; H Punnett; K Shimoya; L Spotila; A Tate; C J Williams
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

5.  Infliximab therapy for hepatic and intestinal sarcoidosis.

Authors:  Helen S Te; Lucas Campbell; Saima Chohan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-06

6.  Sarcoidosis in black women in the United States: data from the Black Women's Health Study.

Authors:  Yvette C Cozier; Jeffrey S Berman; Julie R Palmer; Deborah A Boggs; David M Serlin; Lynn Rosenberg
Journal:  Chest       Date:  2010-07-01       Impact factor: 9.410

7.  18-FDG-PET in a patient cohort suspected for cardiac sarcoidosis: Right ventricular uptake is associated with pathological uptake in mediastinal lymph nodes.

Authors:  Heikki Tuominen; Atte Haarala; Antti Tikkakoski; Mika Kähönen; Kjell Nikus; Kalle Sipilä
Journal:  J Nucl Cardiol       Date:  2018-05-02       Impact factor: 5.952

8.  Use of insurance claims data to determine prevalence and confirm a cluster of sarcoidosis cases in Vermont.

Authors:  Lori A Cragin; A Scott Laney; Cortland J Lohff; Brennan Martin; John A Pandiani; Lynn Z Blevins
Journal:  Public Health Rep       Date:  2009 May-Jun       Impact factor: 2.792

9.  Sarcoidosis in the United States--1968 to 1984. Hospitalization and death.

Authors:  R F Gillum
Journal:  J Natl Med Assoc       Date:  1988-11       Impact factor: 1.798

10.  Reproductive and hormonal factors in relation to incidence of sarcoidosis in US Black women: The Black Women's Health Study.

Authors:  Yvette C Cozier; Jeffrey S Berman; Julie R Palmer; Deborah A Boggs; Lauren A Wise; Lynn Rosenberg
Journal:  Am J Epidemiol       Date:  2012-09-11       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.